O'Callaghan JP - Search Results

1

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P. Fienberg AA, et al. Science. 1998 Aug 7;281(5378):838-42. doi: 10.1126/science.281.5378.838. Science. 1998. PMID: 9694658

2

Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice.

Mani SK, Fienberg AA, O'Callaghan JP, Snyder GL, Allen PB, Dash PK, Moore AN, Mitchell AJ, Bibb J, Greengard P, O'Malley BW. Mani SK, et al. Science. 2000 Feb 11;287(5455):1053-6. doi: 10.1126/science.287.5455.1053. Science. 2000. PMID: 10669419

3

The impact of gender and estrogen on striatal dopaminergic neurotoxicity.

Miller DB, Ali SF, O'Callaghan JP, Laws SC. Miller DB, et al. Ann N Y Acad Sci. 1998 May 30;844:153-65. Ann N Y Acad Sci. 1998. PMID: 9668673

4

Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.

Miller DB, O'Callaghan JP, Ali SF. Miller DB, et al. Ann N Y Acad Sci. 2000 Sep;914:194-207. doi: 10.1111/j.1749-6632.2000.tb05196.x. Ann N Y Acad Sci. 2000. PMID: 11085321

5

Phosphorylation of protein phosphatase inhibitor-1 by Cdk5.

Bibb JA, Nishi A, O'Callaghan JP, Ule J, Lan M, Snyder GL, Horiuchi A, Saito T, Hisanaga S, Czernik AJ, Nairn AC, Greengard P. Bibb JA, et al. J Biol Chem. 2001 Apr 27;276(17):14490-7. doi: 10.1074/jbc.M007197200. Epub 2001 Jan 29. J Biol Chem. 2001. PMID: 11278334 Free article.

6

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.

Snyder GL, Vanover KE, Zhu H, Miller DB, O'Callaghan JP, Tomesch J, Li P, Zhang Q, Krishnan V, Hendrick JP, Nestler EJ, Davis RE, Wennogle LP, Mates S. Snyder GL, et al. Psychopharmacology (Berl). 2015 Feb;232(3):605-21. doi: 10.1007/s00213-014-3704-1. Epub 2014 Aug 15. Psychopharmacology (Berl). 2015. PMID: 25120104 Free PMC article.

7

The interactions of MK-801 with the amphetamine analogues D-methamphetamine (D-METH), 3,4-methylenedioxymethamphetamine (D-MDMA) or D-fenfluramine (D-FEN): neural damage and neural protection.

Miller DB, O'Callaghan JP. Miller DB, et al. Ann N Y Acad Sci. 1993 May 28;679:321-4. doi: 10.1111/j.1749-6632.1993.tb18315.x. Ann N Y Acad Sci. 1993. PMID: 8099774 No abstract available.

8

Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interactions with stress and the adrenal system.

Miller DB, O'Callaghan JP. Miller DB, et al. Ann N Y Acad Sci. 1996 Oct 31;801:148-67. doi: 10.1111/j.1749-6632.1996.tb17438.x. Ann N Y Acad Sci. 1996. PMID: 8959030

9

Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

O'Callaghan JP, Miller DB, Reinhard JF Jr. O'Callaghan JP, et al. Brain Res. 1990 Jun 25;521(1-2):73-80. doi: 10.1016/0006-8993(90)91526-m. Brain Res. 1990. PMID: 1976416

10

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity.

Miller DB, Ali SF, O'Callaghan JP, Laws SC. Miller DB, et al. Ann N Y Acad Sci. 1998 May;844(1):153-165. doi: 10.1111/j.1749-6632.1998.tb08230.x. Ann N Y Acad Sci. 1998. PMID: 29090819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters